» Articles » PMID: 39312148

Datasets for Benchmarking RNA Design Algorithms

Overview
Specialty Molecular Biology
Date 2024 Sep 23
PMID 39312148
Authors
Affiliations
Soon will be listed here.
Abstract

RNA molecules play vital roles in many biological processes, such as gene regulation or protein synthesis. The adoption of a specific secondary and tertiary structure by RNA is essential to perform these diverse functions, making RNA a popular tool in bioengineering therapeutics. The field of RNA design responds to the need to develop novel RNA molecules that possess specific functional attributes. In recent years, computational tools for predicting RNA sequences with desired folding characteristics have improved and expanded. However, there is still a lack of well-defined and standardized datasets to assess these programs. Here, we present a large dataset of internal and multibranched loops extracted from PDB-deposited RNA structures that encompass a wide spectrum of design difficulties. Furthermore, we conducted benchmarking tests of widely utilized open-source RNA design algorithms employing this dataset.

References
1.
Liang J, Bloom R, Smolke C . Engineering biological systems with synthetic RNA molecules. Mol Cell. 2011; 43(6):915-26. PMC: 3176441. DOI: 10.1016/j.molcel.2011.08.023. View

2.
Zhou T, Dai N, Li S, Ward M, Mathews D, Huang L . RNA design via structure-aware multifrontier ensemble optimization. Bioinformatics. 2023; 39(39 Suppl 1):i563-i571. PMC: 10311297. DOI: 10.1093/bioinformatics/btad252. View

3.
Blazewicz J, Figlerowicz M, Kasprzak M, Nowacka M, Rybarczyk A . RNA partial degradation problem: motivation, complexity, algorithm. J Comput Biol. 2011; 18(6):821-34. DOI: 10.1089/cmb.2010.0153. View

4.
Serganov A, Patel D . Ribozymes, riboswitches and beyond: regulation of gene expression without proteins. Nat Rev Genet. 2007; 8(10):776-90. PMC: 4689321. DOI: 10.1038/nrg2172. View

5.
Zhao M, Wang R, Yang K, Jiang Y, Peng Y, Li Y . Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis. Acta Pharm Sin B. 2023; 13(3):916-941. PMC: 10031267. DOI: 10.1016/j.apsb.2022.10.019. View